blue planet methylene blue
aristopet pty ltd - methylene blue - misc. fish tank medication - methylene blue dye-blue active 12.0 mg/ml - parasiticides - fish aquarium freshwater | fish egg | cold water | tropical - fungal infection | white spot | whitespot
methylene blue injection usp solution
hikma canada limited - methylene blue - solution - 10mg - methylene blue 10mg - antidotes
mircera- methoxy polyethylene glycol-epoetin beta injection, solution
vifor (international) inc. - methoxy polyethylene glycol-epoetin beta (unii: lr3uxn0193) (methoxy polyethylene glycol-epoetin beta - unii:lr3uxn0193) - methoxy polyethylene glycol-epoetin beta 30 ug in 0.3 ml - mircera is indicated for the treatment of anemia associated with chronic kidney disease (ckd) in: limitations of use mircera is not indicated and is not recommended: mircera has not been shown to improve symptoms, physical functioning, or health-related quality of life. mircera is contraindicated in patients with: risk summary available data from a small number of published case reports and postmarketing experience with mircera use in pregnancy are insufficient to identify a drug associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. chronic kidney disease is associated with maternal and embryo-fetal risks (see clinical considerations) . in animal reproduction studies, administration of methoxy polyethylene glycol-epoetin beta to rats and rabbits during pregnancy and lactation adversely affected offspring at doses 17-fold and greater than the recommended human dose (see data) . the estimated background risk of major birth defects and miscarriage for the indicated populatio
gavilyte - c tm- polyethylene glycol-3350 and electrolytes with flavor pack powder, for solution
lupin pharmaceuticals,inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37), sodium sulfate anhydrous (unii: 36kcs0r750) (sodium sulfate anhydrous - unii:36kcs0r750) - polyethylene glycol 3350 240 g in 278.26 g - gavilyte- c with flavor pack is indicated for bowel cleansing prior to colonoscopy or barium enema x-ray examination. gavilyte- c with flavor pack is contraindicated in patients known to be hypersensitive to any of the components. gavilyte- c with flavor pack is contraindicated in patients with ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or toxic megacolon.
peg-3350 and electrolytes- polyethylene glycol 3350, sodium chloride, potassium chloride, sodium bicarbonate, and sodium sulfate
lannett company, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37), sodium sulfate (unii: 0ypr65r21j) (sodium cation - unii:lyr4m0nh37) - polyethylene glycol 3350 240 g in 4 l - peg-3350 & electrolytes is indicated for bowel cleansing prior to colonoscopy or barium enema x-ray examination. peg-3350 & electrolytes is contraindicated in patients known to be hypersensitive to any of the components. peg-3350 & electrolytes is contraindicated in patients with ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or toxic megacolon.
health mart lubricating tears- polyethylene glycol 400, propylene glycol solution/ drops
strategic sourcing services llc - polyethylene glycol 400 (unii: b697894sgq) (polyethylene glycol 400 - unii:b697894sgq), propylene glycol (unii: 6dc9q167v3) (propylene glycol - unii:6dc9q167v3) - polyethylene glycol 400 0.4 g in 100 ml - purpose polyethylene glycol 400............. lubricant propylene glycol............ lubricant uses • for the temporary relief of burning and irritation due to dryness of the eye
polyethylene glycol 3350 powder, for solution
atlantic biologicals corps - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - for the treatment of occasional constipation. this product should be used for 2 weeks or less or as directed by a physician. polyethylene glycol 3350 nf is contraindicated in patients with known or suspected bowel obstruction and patients known to be allergic to polyethylene glycol.
peg-3350, electrolytes, and ascorbate- polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, sodium asc
oceanside pharmaceuticals - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - polyethylene glycol-3350, electrolytes, and ascorbate for oral solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults. polyethylene glycol-3350, electrolytes, and ascorbate for oral solution is contraindicated in the following conditions: risk summary there are no available data on polyethylene glycol-3350, electrolytes, and ascorbate for oral solution in pregnant women to inform a drug-associated risk for adverse developmental outcomes. animal reproduction studies have not been conducted with polyethylene glycol-3350, electrolytes, and ascorbate for oral solution. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. risk summary the
methylene blue inj- methylene blue anhydrous injection, solution
cameron pharmaceuticals - methylene blue anhydrous (unii: 8nap7826ub) (methylene blue cation - unii:zmz79891zh) - drug-induced methemoglobinemia. methylene blue can cause fetal harm when administered to a pregnant woman. an association exists between the use of methylene blue in amniocentesis and atresia of the ileum and jejunum, ileal occlusions, and other adverse effects in the neonate. (2, 3) methylene blue is contraindicated in women who are or may become pregnant. if this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. intraspinal and subcutaneous injections are contraindicated. methylene blue is contraindicated in patients with a known hypersensitivity to the drug.
methylene bis(thiocyanate)
buckman laboratories pty ltd - methylene bis(thiocyanate) - unknown - methylene bis(thiocyanate) cyanide active 0.0 - active constituent